Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Incurable Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03669497
What this trial is testing

Hypo-Fractionated Radiotherapy in Breast Cancer

Who this might be right for
Breast CancerAdvanced Breast CancerMetastatic Breast Cancer
Tata Medical Center 33
Not applicableEnded earlyNCT01902966
What this trial is testing

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

Who this might be right for
Cervical Cancer
M.D. Anderson Cancer Center 6
Early research (Phase 1)Ended earlyNCT03166631
What this trial is testing

A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread

Who this might be right for
NeoplasmsNeoplasm MetastasisCarcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 62
Early research (Phase 1)UnknownNCT00002887
What this trial is testing

Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Ottawa Regional Cancer Centre 30
Not applicableUnknownNCT02751723
What this trial is testing

Assessment of Disease Burden and Palliative Care Needs of Patients During the Course of Incurable Cancer Disease

Who this might be right for
Cancer Disease, Palliative Therapy
Florian Lordick, MD 500
Testing effectiveness (Phase 2)Looking for participantsNCT07521852
What this trial is testing

A Phase IIa, Single-arm, Open-label Clinical Study to Evaluate the Efficacy, Safety and PK of CVM-1118 in Combination With Sintilimab and TACE in Participants With Incurable/Non-metastatic HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
TaiRx, Inc. 40
Early research (Phase 1)Study completedNCT00648102
What this trial is testing

Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer

Who this might be right for
Breast CancerColorectal CancerPancreatic Cancer+2 more
Celldex Therapeutics 36
Early research (Phase 1)Active Not RecruitingNCT04460937
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers

Who this might be right for
Clinical Stage III Esophageal Adenocarcinoma AJCC v8Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+56 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT00740571
What this trial is testing

Amitriptyline or Pregabalin to Treat Neuropathic Pain in Incurable Cancer

Who this might be right for
CancerNeuralgia
Radboud University Medical Center 130
Large-scale testing (Phase 3)Study completedNCT02031744
What this trial is testing

The Efficacy and Safety of MetMAb Combined With Tarceva in Patients With Met-Positive Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 530
Testing effectiveness (Phase 2)WithdrawnNCT00003514
What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for
Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more
Burzynski Research Institute
Not applicableLooking for participantsNCT04343365
What this trial is testing

Generating Novel Therapeutic Strategies Based on Evolutionary Tumor Board

Who this might be right for
Incurable Disease
H. Lee Moffitt Cancer Center and Research Institute 35
Early research (Phase 1)Study completedNCT00107250
What this trial is testing

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

Who this might be right for
Colorectal CancerLung CancerUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 50
Not applicableLooking for participantsNCT05695638
What this trial is testing

Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment

Who this might be right for
Solid Tumor, Unspecified, AdultHaematological Malignancy
Morten Ladekarl 3,000
Large-scale testing (Phase 3)Study completedNCT02394795
What this trial is testing

Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC

Who this might be right for
Colorectal Cancer
Takeda 823
Early research (Phase 1)Study completedNCT01065025
What this trial is testing

Open Label, Dose Escalation Trial of Oral Eg5 Kinesin-spindle Inhibitor 4SC-205 in Patients With Advanced Malignancies

Who this might be right for
Advanced and Incurable Solid TumorsMalignant Lymphomas
4SC AG 60
Early research (Phase 1)Study completedNCT01597193
What this trial is testing

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Who this might be right for
Breast Cancer
Pfizer 101
Early research (Phase 1)Study completedNCT01393509
What this trial is testing

The First-in-human Phase I Trial of PU-H71 in Patients With Advanced Malignancies

Who this might be right for
Metastatic Solid TumorLymphomaMyeloproliferative Neoplasms (MPN)
Memorial Sloan Kettering Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT00265057
What this trial is testing

Study of ADH-1 Given Intravenously to Patients With Solid Tumors

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07323641
What this trial is testing

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell Carcinoma
Jonsson Comprehensive Cancer Center 60
Next Page
4